[HTML][HTML] Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model
B Woods, L Schmitt, D Jankovic… - Health Technology …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND To limit the use of antimicrobials without disincentivising the development of
novel antimicrobials, there is interest in establishing innovative models that fund …
novel antimicrobials, there is interest in establishing innovative models that fund …
[PDF][PDF] Final report for the technology evaluation of cefiderocol for treating severe aerobic Gram-negative bacterial infections
Antimicrobial resistance (AMR) develops when bacteria with mutations that prevent the
activity of antimicrobials (AMs) emerge through selection pressure exerted by the use of AM …
activity of antimicrobials (AMs) emerge through selection pressure exerted by the use of AM …
[DOC][DOC] Protocol for the technology evaluation of cefiderocol for treating severe aerobic Gram-negative bacterial infections
The views expressed are those of the author (s) and not necessarily those of the NHS, the
National Institute for Health Research, the Department of Health and Social Care or its arm's …
National Institute for Health Research, the Department of Health and Social Care or its arm's …